Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature
- PMID: 24257431
- PMCID: PMC4000157
- DOI: 10.1097/MOU.0000000000000011
Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature
Abstract
Purpose of review: To present the recent advances in needle guidance and robotic ultrasound technology which are used for prostate cancer (PCa) diagnosis and management.
Recent findings: Prostate biopsy technology has remained relatively unchanged. Improved needle localization and precision would allow for better management of this common disease. Robotic ultrasound and needle guidance is one strategy to improve needle localization and diagnostic accuracy of PCa. This review focuses on the recent advances in robotic ultrasound and needle guidance technologies, and their potential impact on PCa diagnosis and management.
Summary: The use of robotic ultrasound and robotic-assisted needle guidance has the potential to improve PCa diagnosis and management.
Conflict of interest statement
Conflict of Interest:
Deborah Kaye – None
Misop Han – None
Dan Stoianovici - None
Figures


References
-
- Stoianovici D. Technology Advances for Prostate Biopsy and Needle Therapies. Editorial. Journal of Urology. 2012 Oct;188(4):1074–1075. http://urobotics.urology.jhu.edu/pub/2012-stoianovici-jurol.pdf. This editorial describes the implications that biopsy techniques and technology may have on the overdiagnosis of clinically insignificant prostate cancer and underdiagnosis of potentially lethal cancer, and summarizes the state of the art and future directions for biopsy and therapeutic image-guided needle interventions. - PubMed
-
- Rabbani FSN, Kava BR, et al. Incidence and clinical signficance of false-negative sextant prostate biopsies. J Urol. 1998;159:1247. - PubMed
-
- Norberg MEL, Holmberg L, et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997;50:562. - PubMed
-
- Svetec DMK, Perestsman S, et al. Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. J Urol. 1998;159:1606. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials